# Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma

> **NCT03151876** · PHASE2 · UNKNOWN · sponsor: **Sichuan University** · enrollment: 93 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Chidamide
- **DRUG:** Cladribine
- **DRUG:** gemcitabine
- **DRUG:** Busulfan
- **PROCEDURE:** Autologous hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT03151876
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-12
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 93 (ESTIMATED)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03151876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03151876, "Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03151876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*